Authors
Loading...
Clinical and preclinical evidence suggests probiotics can reduce inflammation in Alzheimer's and Parkinson's diseases, implying potential therapeutic roles.
Córdova et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: